P239: Ulcerative Colitis Index of Severity is a better predictor of histologic activity than Mayo endoscopic subscore, an Asian cohort study in ulcerative colitis.ECCO'22Year: 2022
Authors: Tay, S.(1);Teh, K.K.J.(1);Wang, L.M.(2);Tan, M.(1);
(1)Singapore General Hospital, Gastroenterology and Hepatology, Singapore, Singapore;(2)Changi General Hospital, Pathology, Singapore, Singapore;
P241: Advantages of a fully automated chemiluminescent method for therapeutic drug monitoring (TDM) of anti-TNFα in patients with Inflammatory Bowel Diseases. ECCO'22Year: 2022
Authors: Cifù, A.(1);Marino, M.(2);Sablich, R.(3);Carletti, M.(4);Blasone, N.(4);Milloch, S.(4);Curcio, F.(1);Fabris, M.(4);
(1)University of Udine, Department of Medicine DAME, Udine, Italy;(2)Azienda Sanitaria Universitaria Friuli Centrale ASUFC, Clinic of Gastroenterology, Udine, Italy;(3)Azienda Sanitaria Friuli Orientale ASFO, Clinic of Gastroenterology, Pordenone, Italy;(4)Azienda Sanitaria Universitaria Friuli Centrale ASUFC, Institute of Clinical Pathology, Udine, Italy;
P242: Latent Tuberculosis: frequency of occurrence and effect on clinical, laboratory, endoscopic and morphological activity of the course Inflammatory Bowel DiseasesECCO'22Year: 2022
Authors: Babayeva-Sadigova, G.(1,2);Makhmudov , U.(3);Asadova , G.(1,4);Quliyev , F.(4);Samadova , T.(1,4);Mirzazade, O.(1);Hasanova , A.(1);
(1)Azerbaijan State Advanced Training Institute for Doctors named after A.ALIYEV., department of therapy, Baku, Azerbaijan;(2)Memorial Klinik, department of therapy and gastroenterology, Baku, Azerbaijan;(3)Modern Hospital, departament of gastroenterology and endoscopy, Baku, Azerbaijan;(4)National Center of Oncology, department of Invasive Diagnosis and Therapy, Baku, Azerbaijan;IBD
P243: Relationship between intestinal ultrasound, fecal calprotectin and Harvey-Bradshaw Index in the assessment of infllamatory activity in Cronh´s DiseaseECCO'22Year: 2022
Authors: Montero Moretón, Á.M.(1);Bastón Rey, I.(2);Calvino Suarez, C.(2);De la Iglesia García, D.(2);Ferreiro Iglesias, R.(2);Maestro Antolín, S.(1);Santos Santamarta, F.(1);Pérez Millán, A.G.(1);Dominguez-Munoz, E.(2);Barreiro-de Acosta, M.(2);
(1)Complejo Asistencial Universitario de Palencia, Gastroenterology, Palencia, Spain;(2)Hospital Clínico Universitario de Santiago, Gastroenterology, Santiago de Compostela, Spain;
P244: COVID-19 vaccine does not increase the likelihood of disease exacerbation in IBD: results from a population-based studyECCO'22Year: 2022
Authors: Lev Zion, R.(1);Focht, G.(1);Lujan, R.(1);Mendelovici, A.(2);Friss, C.(1);Greenfeld, S.(3);Kariv, R.(4);Ben-Tov, A.(5,6);Matz, E.(7);Nevo, D.(8);Barak-Corren, Y.(9);Dotan, I.(10);Turner, D.(1);
(1)Shaare Zedek Medical Center, Department of Pediatric Gastroenterology, Jerusalem, Israel;(2)Shaare Zedek Medical Center, Department of Pediatric Gastroenterology, Jeusalem, Israel;(3)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Medical Informatics, Tel-Aviv, Israel;(4)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Gastroenterology, Tel-Aviv, Israel;(5)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Institute for Research & Innovation, Tel-Aviv, Israel;(6)Dana-Dwek Children's Hospital- Tel-Aviv Sourasky Medical Center, Pediatric Gastroenterology, Tel-Aviv, Israel;(7)Leumit Health Services, Community Medicine, Tel-Aviv, Israel;(8)Tel-Aviv University, Department of Statistics and Operations Research, Tel-Aviv, Israel;(9)Boston Children's Hospital, Predictive Medicine Group, Boston, United States;(10)Rabin Medical Center and the Sackler Faculty of Medicine- Tel Aviv University, Gastroenterology, Petah Tikva, Israel;
P245: Dynemics of the Immune-transcriptome and Microbiome in Paediatric Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Elawad, M.A.(1);Kumar, M.(2);Saadaui, M.(3);Elhag, D.(3);Akobeng, A.(2);Al-Mudahka, F.(2);Hendaus, M.(4);Al Khodor, S.(3);
(1)Sidra Medical and Research Centre, Department of Paediatric Gastroenterology, Doha, Qatar;(2)Sidra Medicine, Department of Paediatric Gastroenterology, Doha, Qatar;(3)Sidra Medicine, Research Department, Doha, Qatar;(4)Sidra Medicine, Pediatrics Department, Doha, Qatar;
P246: Persistent burden of disease in patients with Crohn’s disease treated with biologic therapy: results from a real-world survey in the United States (US), France, Germany, Italy, Spain, and United Kingdom (5EU)ECCO'22Year: 2022
Authors: Sikirica, M.(1);Lynch, J.(2);Kershaw, J.(3);Lukanova, R.(3);Baker, S.(3);Milligan, G.(3);
(1)Janssen, Market Access, Horsham, United States;(2)Janssen Research & Development- LLC, Immunology, Horsham, United States;(3)Adelphi Real World, Autoimmune, Bollington, United Kingdom;
P247: Comparison of discontinuation/switching between infliximab biosimilar and originator among Inflammatory Bowel Disease patients: a real-world analysis of two Canadian cohortsECCO'22Year: 2022
Authors: Moura, C.S.(1);Lukusa, L.(1);Wong, E.C.(2);Lakatos, P.L.(3);Afif, W.(3);Narula, N.(2);Bernatsky, S.(3);
(1)McGill University Health Centre, Centre for Outcomes Research and Evaluation, Montreal, Canada;(2)McMaster University, Department of Medicine Division of Gastroenterology, Hamilton, Canada;(3)McGill University, Department of Medicine, Montreal, Canada;
P248: Lifestyle changes after Inflamatory Bowel Disease diagnosis.ECCO'22Year: 2022
Authors: Belén Galipienso, O.(1);Cameo, J.(1);Bernabeu, P.(2);Mira, C.(1);García, M.D.M.(3);Pomares, C.(4);Muñoz, D.(5);Canales, N.(2);Gutierrez, A.(1);Zapater, P.(6);van-der Hofstadt, C.(2);Jover, R.(1);Ruiz, M.T.(7);Sempere, L.(1);
(1)General University Hospital-Alicante. ISABIAL., Gastroenterology Department, Alicante, Spain;(2)General University Hospital-Alicante. ISABIAL., Health Psychology Department, Alicante, Spain;(3)University Hospital-San Juan, Gastroenterology Department, Alicante, Spain;(4)General University Hospital-Elche, Gastroenterology Department, Elche, Spain;(5)University and Polytechnic La Fe Hospital, Gastroenterology Department, Valencia, Spain;(6)General University Hospital-Alicante. ISABIAL. CIBEREHD, Pharmacology Department, Alicante, Spain;(7)University of Alicante. CIBERESP., Public Health Department, Alicante, Spain;
P249: Serum calprotectin is useful to confirm Inflammatory Bowel Disease activity but is not effective to predict relapse.ECCO'22Year: 2022
Authors: Veyrard, P.(1);Roblin, X.(2);Mao, R.(3);Nancey, S.(4);waeckel, L.(5);Berger, A.E.(6);Williet, N.(7);Bastide, L.(7);Barrau, M.(7);tournier, Q.(7);Paul, S.(6);
(1)CHU SAINT-ETIENNE, gastro enterology, Saint-Priest-en-Jarez, France;(2)chu saint etienne, gastro enterology, Saint-Priest-en-Jarez, France;(3)Hospital of Sun Yat-sen University, Inflammation and immunity, guangzhou, China;(4)chu Lyon sud, Gastroenterology, Lyon, France;(5)chu st etienne, immunology, Saint etienne, France;(6)CHU Saint etienne, Immunology, Saint Etienne, France;(7)CHU saint etienne, Gastroenterology, Saint etienne, France;
P250: Clinical validation of a point of care test for fecal calprotectin in distinguishing irritable bowel syndrome from Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Bray, K.(1);Bahur, B.(2);Yadav, M.(3);Skinner, M.(3);Wong, M.(3);Chon, K.(3);Huang, R.(3);Day, V.(3);Mimms, L.(3);Hale, M.(3);
(1)ProciseDx Inc., Clinical Development and Medical Affairs, San Diego, United States;(2)ProciseDx Inc., Clinical Operations, San Diego, United States;(3)ProciseDx Inc., Research and Development, San Diego, United States;
P251: Endoscopic and pathologic findings of the esophago-gastroduodenal involvement of Crohn’s disease in Korea: a prospective cohort studyECCO'22Year: 2022
Authors: Kim, G.H.(1);Kim, J.(2);Park, S.H.(1);Ahn, J.Y.(1);Ye, B.D.(1);Jung, H.Y.(1);Yang, S.K.(1);
(1)Asan Medical Center University of Ulsan College of Medicine, Gastroenterology, Seoul, Korea- Republic Of;(2)Asan Medical Center University of Ulsan College of Medicine, Pathology, Seoul, Korea- Republic Of;
P252: Low adherence is associated with worse disease course in Ulcerative Colitis: a retrospective study from a single referral center.ECCO'22Year: 2022
Authors: Viola, A.(1);Demarzo, M.G.(2);Abbruzzese, A.(1);Chiappetta, M.F.(1);Costantino, G.(1);Alibrandi, A.(3);Fries, W.(1);
(1)University of Messina., IBD-unit- Dept. of Clinical and Experimental Medicine., Messina, Italy;(2)University of Genoa- Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Gastroenterology Unit- Department of Internal Medicine., Messina, Italy;(3)University of Messina., Department of Economics- Unit of Statistical and Mathematical Sciences, Messina, Italy;
P254: Crohn’s disease of the pouch: an overdiagnosed condition?ECCO'22Year: 2022
Authors: de Jong, D.C.(1);Reijntjes, M.(2);Wessels, E.(1);Buskens, C.(2);Hompes, R.(2);Löwenberg, M.(1);Gecse, K.(1);D'Haens, G.(1);Bemelman, W.(2);Duijvestein, M.(3);
(1)Amsterdam UMC- location AMC- The Netherlands, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC- location AMC- The Netherlands, Department of Surgery, Amsterdam, The Netherlands;(3)Radboudumc, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;
P255: Mirikizumab modulates genes associated with the symptom of bowel urgencyECCO'22Year: 2022
Authors: Krishnan, G.(1);Steere, B.(1);Higgs, R.(1);Wang, Y.C.(1);Harris, C.J.(1);Milch, C.(1);Escobar, R.(1);Reinisch, W.(2);Dubinsky, M.(3);
(1)Eli Lilly and Company, Biomedicines, Indianapolis, United States;(2)Medical University Vienna, Internal Medicine, Vienna, Austria;(3)Icahn School of Medicine at Mount Sinai, Mount Sinai, New York, United States;
P256: The practical use of an eHealth platform for inflammatory bowel disease patients: the validation of the IBD Tool web-based tele-monitoring systemECCO'22Year: 2022
Authors: Giuffrida, E.(1,2);Mangia, M.(1,3);Figini, V.(4);Carli, E.(1);Colombo, A.(1);Mendolaro, M.(1);Lavagna, A.(1);Lia, C.(5);Bonina, M.(5);Martínez De Carnero, F.(5);Morello, E.(1);Cosimato, M.(1);Rocca, R.(1);Pagna, G.(4,5);Daperno, M.(1);
(1)Mauriziano Hospital, Department of Gastroenterology and Endoscopy, Torino, Italy;(2)@Rodolico - S. Marco@ Policlinic Hospital, Gastroenterology Unit, Catania, Italy;(3)ASL TO4 Hospital, Gastroenterology Unit, Ciriè, Italy;(4)LINKS Foundation, LINKS Foundation, Turin, Italy;(5)Polytechnic of Turin, Polytechnic of Turin, Turin, Italy;
P257: The clinical decision support tool has low performance in predicting outcome to ustekinumab in Crohn’s diseaseECCO'22Year: 2022
Authors: Alsoud, D.(1);Sabino, J.(1,2);Ferrante, M.(1,2);Verstockt , B.(1,2);Vermeire, S.(1,2);
(1)KU Leuven, Translational Research in Gastrointestinal Disorders- Department of Chronic Disease- Metabolism and Ageing, Leuven, Belgium;(2)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
P258: Impact of inflammatory bowel diseases on the phenotype and severity of primary sclerosing cholangitis - a systematic review with meta-analysisECCO'22Year: 2022
Authors: Attauabi, M.(1,2,3);Wewer, M.D.(1,3);Bendtsen, F.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3);
(1)Copenhagen University Hospital- Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(2)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;(3)University of Copenhagen- Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;
